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Abstract 
 
Pulmonary circulation could be one of the primary vascular targets of finest particles 
that can deeply penetrate into the lungs after inhalation. We investigated the effects 
of engineered nanoparticles on vasomotor responses of small intrapulmonary arteries 
using isometric tension measurements. Acute in vitro exposure to carbon 
nanoparticles (CNP) decreased, and in some case abolished, the vasomotor 
responses induced by several vasoactive agents, whereas acute exposure to 
titanium dioxide nanoparticles (TiO2NP) did not. This could be attributed to a 
decrease in the activity of those vasoactive agents (including PGF2, serotonin, 
endothelin-1 and acetylcholine), as suggested when they were exposed to CNP 
before being applied to arteries. Also, CNP decreased the contraction induced by 30 
mM KCl, without decreasing its activity. After endoplasmic reticulum calcium stores 
depletion (by caffeine and thapsigargin), CaCl2 addition induced a contraction, 
dependent on Store-Operated Calcium Channels that was not modified by acute 
CNP exposure. Further addition of 30 mM KCl elicited a contraction, originating from 
activation of Voltage-Operated Calcium Channels that was diminished by CNP. 
Contractile responses to PGF2 or KCl, and relaxation to acetylcholine were modified 
neither in pulmonary arteries exposed in vitro for prolonged time to CNP or TiO2NP, 
nor in those removed from rats intratracheally instilled with CNP or TiO2NP. In 
conclusion, prolonged in vitro or in vivo exposure to CNP or TiO2NP does not affect 
vasomotor responses of pulmonary arteries. However, acute exposure to CNP 
decreases contraction mediated by activation of Voltage-Operated, but not Store-
Operated, Calcium Channels. Moreover, interaction of some vasoactive agents with 
CNP decreases their biological activity that might lead to misinterpretation of 
experimental data. 
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Introduction 
 
Ultrafine particles are defined as particles with a nominal diameter of 100 nm or less. 
They have been, for a long time, only considered as an important component of 
ambient particulate pollution, being responsible for the high incidence of cardio-
pulmonary morbidity and mortality reported by epidemiological studies (Pope et al., 
1991 ; Poloniecki et al., 1997 ; Samet et al., 2000 ; Hoek et al., 2002 ; Peng et al., 
2008). Nowadays, with the development of nanotechnology, nanoparticles are 
recognized as an important class of new-engineered materials, with a wide range of 
industrial and biomedical applications for the diagnosis and the treatment of diseases 
(De Jong and Borm, 2008 ; Sandhiya et al., 2009). Those nanoparticles are defined 
with a nominal diameter smaller than 100 nm. Whatever the origin of those particles, 
the underlying mechanisms of their potential deleterious effects on health remain 
poorly understood, and are a matter of intensive research. 
 
Regarding composition, ultrafine particles may be extremely heterogeneous, 
depending on emission sources. Various constituents, such as transition metals and 
organic or inorganic compounds, can be adsorbed onto ultrafine particles’ cores 
derived from combustion process. Compared to ultrafine particles from atmospheric 
pollution, engineered nanoparticles are relatively homogenous in size and 
composition, and relatively free of adsorbed constituents. Thus, manufactured 
nanoparticles, especially carbon or titanium dioxide nanoparticles, could be relevant 
surrogate for airborne particulate matter (Donaldson et al., 2003), and are frequently 
used in order to discriminate which components (i.e. particulate core, adsorbed 
constituent or both) are responsible for their deleterious health effects. 
 
Likely because they can deeply penetrate into the lungs after inhalation, such 
ultrafine fractions produce enhanced pulmonary adverse effects, when compared to 
larger particles of similar composition (Warheit et al., 2008). Alteration of vasomotor 
responses by particulate matter has been described in different vascular beds, 
including the pulmonary circulation, which could be one of the primary vascular 
targets of inhaled particles (Courtois et al., 2008). It was shown that particles from 
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urban pollution could affect the NO dependant relaxation pathway, probably by 
decreasing the activity of cytosolic guanylyl cyclase. In most animal (rat or rabbit) or 
human studies, in vivo or in vitro exposure to fine PM2.5 (with aerodynamic diameter < 
2.5 µm) from urban origin, diesel exhaust or residual-oil fly ash induces 
vasoconstriction (Brook et al., 2002 ; Huang et al., 2002 ; Li et al., 2005 ; Mills et al., 
2005). Such vasoconstrictor effect may contribute to enhance arterial resistances and 
pressure, which in turn, may have negative impact on cardiac function. However, 
some other reports demonstrate a relaxant effect of systemic vessels upon exposure 
to particulate matter (Knaapen et al., 2001). Whether nanoparticles exert a similar 
effect, i.e. vasoconstriction or vasodilatation, in the pulmonary vasculature is largely 
unknown. 
 
In this study, we have therefore investigated the effect of carbon nanoparticles (CNP) 
or titanium dioxide nanoparticles (TiO2NP) on the vasomotor response induced by a 
variety of agents in small rat intrapulmonary arteries using isometric tension 
measurements. The influence of acute or long-term in vitro treatment with CNP or 
TiO2NP, as well as that of in vivo instillation, has been examined. Responses induced 
by both contractile agents acting on vascular smooth muscle (following activation of 
plasma membrane receptors, or direct activation of calcium entry through opening of 
Voltage-Operated or Store-Operated Calcium Channels, i.e. VOCC and SOCC 
respectively), and relaxing agents acting either on vascular smooth muscle (via the 
intracellular messengers cyclic AMP or cyclic GMP) or endothelium (via the release 
of endothelial NO, which in turn activates cyclic GMP pathway) were analysed. 
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Methods 
 
Chemicals. 
 
Each salts for physiological salt solution (PSS) preparation, 3-[(3-cholamido-
propyl)dimethylammonio]-1-propanasulfonate (CHAPS), acetylcholine chloride, 
phenylephrine, sodium nitroprusside, forskoline, endothelin-1, serotonin, U-46619, 
thapsigargin, 2-aminoethyl diphenylborinate, nicardipine and caffeine were 
purchased from Sigma Chemical Co. (St Quentin-Fallavier, France). Prostaglandin 
F2 (PGF2, Dinolytic
®) was purchased from Centravet (Libourne, France). Carbon 
nanoparticles, i.e. CNP (primary particle size of 13-14 nm), and titanium dioxide 
nanoparticles, i.e. TiO2NP (primary particle size of 15 nm), were obtained from 
Degussa (Germany) and Sigma Chemical Co. (St Quentin-Fallavier, France), 
respectively. Those nanomaterials were already described in more details according 
to their morphology and surface reactivity (Rouzaud et al., 2004 ; Xia et al., 2006 ; 
Setyan et al., 2009). Nanoparticles (CNP and TiO2NP) were suspended in deionised 
water (final concentration of 10 mg/ml) and were subjected to sonication before use. 
 
Treatment of vasoactive agents with CNP. 
 
Vasoactive agents were incubated in PSS (containing in mM: 119 NaCl, 4.7 KCl, 1.5 
CaCl2, 1.17 MgSO4, 1.18 KH2PO4, 25 NaHCO3 and 5.5 glucose) in the presence of 
200 µg/ml CNP at 37°C. After 15 minutes incubation period, nanoparticles were 
pelleted by centrifugation (11 000 g, 15 min). The supernatant was collected for 
evaluation of biological activity (see below). In addition, phenylephrine water 
concentrations was assayed before addition of CNP and in the supernatant collected 
after incubation with CNP by LC-MS/MS (see below). 
 
Measurement of phenylephrine concentrations after exposure to CNP by LC-
MS/MS. 
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Phenylephrine water solutions (2 µl), collected before and after nanoparticles 
exposure, were injected into a liquid chromatography-tandem mass spectrometry 
system. The LC-MS/MS method consisted of an Acquity UPLC® separation module 
coupled with an Acquity TQD® detector with electrospray ionisation in positive ion 
mode. The chromatographic separation was performed at 25°C on an XTerra RP C18 
column (100x2.1mm; 5µm, Waters). The mobile phase consisted of a gradient of 
acetonitrile (A) and ammonium formate buffer (B) (4 mmol/l; pH 3.4) at 0.2ml/min flow 
rate. The mobile phase started at 2% (A); linearly increased to 35% in 4min and kept 
for 1min then decreased to 2%, with total separation time of 7min.  
The MS system was operated with a capillary voltage of 1kV, a source temperature 
of 115°C and a drying gas temperature of 300°C. Argon was used as collision gas 
(0.2 ml/min flow rate). The multiple reaction monitoring was performed by monitoring 
the transitions between m/z parent and daughter ion: 168.2>150 (phenylephrine). 
The cone voltage was set at 22V and the collision energy at 10eV. The method is 
validated with a good linearity between 5 10-7 to 5 10-5 M (i.e. 100-10000ng/ml; r2 > 
0.995) for phenylephrine. 
 
Animals, exposition to CNP and TiO2NP and tissue preparation. 
 
Healthy male Wistar or Sprague-Dawley rats, weighing 400-550 g (10-14 weeks old), 
were obtained from Elevage Janvier (Le Genest Saint Isle, France). Animals were 
housed in a regulated animal facility where 12 h light/dark cycle was maintained. The 
rats were fed with standard animal food and water received ad libitum. The 
investigation conforms to the Guiding Principles for the Use of Animals in Toxicology, 
which were adopted by the Society of Toxicology in 1989. Agreement (number A 
33409) was obtained by French authorities. 
Intralobar pulmonary arteries (2nd order branch, internal diameter 500 - 800 µm) were 
dissected from male Wistar rats and mounted in wire myograph, as previously 
described (Courtois et al., 2008). In some cases, endothelium was chemically 
removed before mounting arterial segments in myograph, by perfusion of a non-
denaturating zwitterionic detergent CHAPS (0.3 %), as previously described 
(Pourageaud et al., 2005). In another set of experiments, intrapulmonary arteries 
were first incubated in DMEM for 24 h at 37°C in a humidified atmosphere of 95% air 
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/ 5% CO2, in absence or presence of CNP or TiO2NP (200 µg/ml) and then carefully 
washed with PSS before mounting in myograph. 
Finally, some experiments were also performed in intralobar pulmonary arteries 
removed from Sprague-Dawley rats, which were previously instilled with CNP or 
TiO2NP. For these experiments, rats were anesthetised with ketamine (50 mg/kg) 
and xylazine (4 mg/kg), and intratracheally instilled with 100 µg of carbon or titanium 
dioxide nanoparticles in 0.5 ml of saline (NaCl 0.9 %) or saline alone. After a 21 days 
recovery period, intrapulmonary arteries were prepared and mounted in myograph as 
previously described (Courtois et al., 2008). 
 
After 60 min of equilibration period under resting tone, a PSS containing 80 mM KCl 
(equimolar substitution with NaCl) was added to organ bath in order to obtain a 
maximal contraction and ascertain the viability of our preparation. Arteries developing 
a wall tension below 1 mN.mm-1 were discarded. Washout with normal PSS allowed 
recovery of resting tone. Arteries were then submaximally pre-contracted with PGF2α, 
and once contraction reached a steady-state level, acetylcholine (an agent which 
produces endothelium-dependent relaxation) was applied. While 30 µM acetylcholine 
produced 68.23 + 3.51 % relaxation (n = 10) in control arteries, it failed to produce 
significant relaxation in CHAPS-treated ones (-0.09 + 1.65 % relaxation, n = 6). 
 
Experimental protocols. 
 
In order to assess the direct effect of nanoparticles on vascular tone, intrapulmonary 
arteries were first submaximally contracted with 10 μM PGF2α or 30 mM KCl. Once 
stable contraction was obtained, cumulative concentrations of nanoparticles, i.e. CNP 
or TiO2NP (0 - 200 µg/ml) were added and wall tension was recorded. 
 
In experiments in which interaction between contractile agents and CNP was 
investigated, solutions of nanoparticle-treated contracting agents (PGF2α, 10 µM; U-
46619, 0.3 µM; phenylephrine, 0.3 µM; serotonin, 30 µM; endothelin-1, 30 nM; and 
KCl, 30 mM) were added to the organ bath. In experiments in which relaxant agents 
were studied, intrapulmonary arteries were submaximally contracted with PGF2α (10 
μM). Once stable contraction was obtained, nanoparticle-treated solution of 
acetylcholine (10 µM), forskoline (0.3 µM) or sodium nitroprusside (1 µM) was added. 
 9 
The concentrations of these agents were chosen from preliminary experiments to 
produce between 40 - 80 % of their maximal effect. The effect of nanoparticle-treated 
vasoactive agents was compared to that of untreated-ones, which was determined 
either in the same or in a different arterial preparation, depending on the 
reproducibility of the response. 
 
The effect of CNP on the Store-Operated Calcium Channels (SOCC) component of 
contraction was determined according to the following protocol. To ensure calcium 
store depletion, endothelium-denuded intrapulmonary arteries were bathed for 30 
min in calcium-free PSS (119 mM NaCl, 4.7 mM KCl, 1.17 mM MgSO4, 1.18 mM 
KH2PO4, 25 mM NaHCO3 and 5.5 mM glucose), in the presence of thapsigargin (1 
µM) and caffeine (5 mM). After washout in calcium-free PSS, CaCl2 (1.5 mM) was 
added to organ bath. Exposure to calcium induced a contractile response, which is 
inhibited by 4.10-5 M of 2-aminoethyl diphenylborinate (a SOCC inhibitor, Park et al., 
2008), and therefore attributed to calcium influx from SOCC (Marthan, 2004). Once 
stable level of contraction was obtained, CNP (100 µg/ml) were added. For 
evaluation of the effect of CNP on the Voltage-Operated Calcium Channels (VOCC) 
component of contraction, endothelium-denuded intrapulmonary arteries were 
exposed to calcium-free PSS, thapsigargin, caffeine and CaCl2. Such protocol 
induced a contractile response attributed to calcium influx from SOCC as described 
above. Then KCl (30 mM) was added to organ bath. Under these conditions, KCl-
induced second contraction, which is inhibited by 10-5 M of nicardipine (a VOCC 
inhibitor), was attributed to calcium influx through VOCC (Marthan, 2004). Once 
stable contraction to KCl was achieved, CNP (100 µg/ml) were added. 
 
In another set of experiments, intrapulmonary arteries which were previously 
incubated for 24 h in the absence or presence of CNP or TiO2NP (200 µg/ml) or 
which were removed from saline or CNP- or TiO2NP-instilled rats, were exposed to 
cumulative concentration of PGF2α. After washout, preparations were submaximally 
contracted with PGF2α, and once stable level of contraction was obtained, 
acetylcholine was applied in a cumulative manner. 
 
Data Expression and Statistical Analysis. 
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Contractile responses are expressed in wall tension (mN.mm-1). Relaxant responses 
are expressed as the percentage of decrease of the initial tone induced by either 
PGF2α or KCl. Data are given as means ± s.e.m from n experiments (with n: number 
of rats). Concentration-response curves were compared using two-way analysis of 
variance (ANOVA). Student t test (paired or unpaired, as appropriate) was used for 
other statistical comparisons. Differences were considered statistically significant 
when P < 0.05. 
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Results 
 
Effect of acute in vitro treatment with CNP or TiO2NP on vasomotor responses 
induced by various agents. 
 
Effect of increasing concentration of CNP or TiO2NP was evaluated in rat 
intrapulmonary arteries precontracted with 10 µM PGF2α. CNP decreased tone 
concentration-dependently in both endothelium intact and denuded arterial 
preparations (Figure 1). This effect started for a particles concentration of 
approximately 30 µg/ml and was maximal for 200 µg/ml (90.20 ± 2.16 and 85.27 ± 
3.82 percent decrease of tone, in endothelium intact and endothelium denuded 
arteries, respectively). By contrast, TiO2NP failed to alter vascular tone in 
endothelium intact arteries (Figure 1) whatever the particles concentration used. 
 
To assess whether this relaxing effect could be attributed to an effect of CNP on 
arterial tissue or to a direct interaction of these nanoparticles with the contractile 
agonist, PGF2α was exposed to CNP, before being applied to intrapulmonary arteries 
(see methods). As shown in Figure 2b, previous exposure of PGF2α to CNP resulted 
in a strong diminution of PGF2α-induced contraction, compared to the effect of 
untreated PGF2α (Figure 2a). 
 
In order to assess whether this effect of CNP was restricted to PGF2α or could also 
occur with alternative vasoactive agents with different physico-chemical properties, 
the biological activity of several contracting or relaxant agents was assessed, after 
exposure or not to CNP. As summarized in Table 1, not only contractile responses to 
PGF2α and U46619 (fatty-acid derivatives) but also those of other agonists of G-
protein coupled receptors such as the hydrophilic amine derivatives phenylephrine 
and 5-HT, and those of the 21 amino acid peptide ET-1 were markedly decreased 
after exposure to CNP. Vasorelaxant responses to acetylcholine (a hydrophilic 
quaternary ammonium compound, which induces endothelium and NO-dependent 
relaxant effect, Figure 2c and 2d, Table 1) and to forskoline (a diterpene from 
Coleus forskohlii, which induces cyclic AMP-dependent relaxation, Table 1) were 
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also markedly diminished after exposure to CNP. By contrast, vasomotor responses 
elicited by the inorganic compounds KCl (which triggers the opening of voltage-
dependent calcium channels and induces contraction) or sodium nitroprusside (which 
induces NO-dependent but endothelium-independent relaxation) were not affected by 
CNP (Table 1). 
 
In addition the concentrations of phenylephrine, either unexposed or exposed to 
carbon nanoparticles, were evaluated by liquid chromatography-tandem mass 
spectrometry. In unexposed phenylephrine, we measured a concentration of 31.57 ± 
0.6 µM, whereas in these same nanoparticles-exposed solutions phenylephrine 
concentration was 27.61 ± 0.16 µM (p < 0.01). It is important to notice that these 
concentrations used are in the same range of the concentrations used to detect an 
adsorption of vasoactive agent onto particles surfaces by functional experiments. 
 
Effect of acute in vitro treatment with CNP on vasomotor response induced by 
KCl. 
 
Since the aboved-mentionned experiments demonstrated the absence of CNP direct 
interaction with KCl; we have tempted to evaluate CNP direct effect on smooth 
muscle contraction, the effect of these nanoparticles was studied in endothelium-
denuded KCl-precontracted intrapulmonary arteries. After precontraction with 30 mM 
KCl, CNP produced a significant and concentration-dependent decrease in tone (25 
% for 200 µg/ml CNP), as compared to time-matched control vessels (Figure 3). 
 
Vascular smooth muscle contraction to KCl is mainly initiated by a rise in cytoplasmic 
calcium concentration following extracellular calcium entry. The following 
experiments were designed to evaluate the effect of CNP on two types of channels 
involved in such entry, namely Store-Operated Calcium Channels (SOCC) and 
Voltage-Operated Calcium Channels (VOCC). To study SOCC component, 
endoplasmic reticulum calcium stores were first depleted by concomitant addition of 
thapsigargin (SERCA inhibitor) and caffeine (which induces calcium release by 
activation of ryanodine receptors) in arterial preparations bathed in calcium-free 
medium (see methods and Figure 4 for experimental protocol). After washout with 
calcium-free medium (it should be notice that such washout protocol was ineffective 
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to remove thapsigargin), addition of CaCl2 (1.5 mM) induced a contractile response 
(Figure 4a), which is significantly inhibited by 4.10-5 M of 2-aminoethyl 
diphenylborinate (a SOCC inhibitor, Park et al., 2008), and therefore attributed to 
calcium influx from SOCC (data not shown). Further addition of CNP failed to modify 
CaCl2-induced contraction (Figure 4a for a representative trace of arterial tone and 
Figure 4c for statistical analysis from n = 4 experiments). The VOCC component was 
studied after depletion of endoplasmic reticulum calcium store (with thapsigargin and 
caffeine in calcium-free medium). After medium withdrawal and washout with 
calcium-free medium, SOCC was activated by addition of 1.5 mM CaCl2 (see 
methods and Figure 4 for experimental protocol). Subsequent addition of 30 mM KCl 
induced a further contractile response (Figure 4b), which is significantly inhibited by 
10-5 M of nicardipine (a VOCC inhibitor), and therefore attributed to calcium influx 
through VOCC (data not shown). Once stable contraction to KCl was achieved, CNP 
(100 µg/ml) were added. Under these conditions, addition of CNP elicited a 
significant decrease of contraction of about 25 % (Figure 4b for a representative 
trace of arterial tone and Figure 4d for statistical analysis from n = 4 experiments), 
similar to what is shown in figure 3. 
 
Effect of long-term in vitro treatment with CNP or TiO2NP on vasomotor 
responses induced by various agents. 
 
Since acute direct interaction between CNP and some vasoactive agents may mask 
effects of these nanoparticles on arterial tissue, the following series of experiments 
were designed to evaluate whether prolonged exposure of pulmonary arteries to CNP 
could affect their contractile responses. In this set of experiments, intrapulmonary 
arteries were first incubated in culture medium (see methods) in absence or presence 
of 200 µg/ml CNP. After 24 h exposure, arteries were carefully washed with PSS and 
mounted in myograph to evaluate their contractile responses to either PGF2α or KCl, 
or their relaxant responses to acetylcholine. As shown in Figure 5, 24 h exposure of 
intrapulmonary arteries to CNP resulted neither in significant impairment of KCl or 
PGF2α-induced contraction nor of acetylcholine-induced relaxation. Similarly, as 
shown in Figure 6, prolonged exposure to TiO2NP did not modify responses to those 
vasoactive agents. 
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Effect of in vivo treatment with CNP or TiO2NP on vasomotor responses 
induced by various agents. 
 
For these experiments, anesthetised rats were intratracheally instilled with 100 µg 
CNP or TiO2NP particles in 0.5 ml of saline (NaCl 0.9 %) or saline alone as control. 
After a 21 days recovery period, intrapulmonary arteries were prepared and mounted 
in myograph to evaluate ex vivo their vasomotor responses to PGF2α, KCl and 
acetylcholine. As illustrated in Figure 7 and Figure 8, in vivo instillation of CNP or 
TiO2NP altered neither the contractile response to KCl and PGF2α nor the relaxant 
response to acetylcholine. 
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Discussion 
 
The present results indicate that carbon-manufactured nanoparticles, but not titanium 
dioxide nanoparticles, alter rat intralobar pulmonary arteries reactivity. However, we 
also suggest a binding of organic (but not inorganic) pharmacological agents to 
carbon-manufactured nanoparticles. Such binding reduces the biological activity of 
these pharmacological agents. This nanoparticle-induced alteration in agonist 
biological activity should be systematically investigated to avoid misinterpretation of 
experimental results. 
 
Depending of emission sources, airborne particulate matter is extremely 
heterogeneous in terms of core size and composition. Regarding particulate matter, 
the ultrafine fraction is considered to produce the most hazardous health effect 
(Donaldson et al., 2001). Additionally, various constituents from mineral, organic or 
biologic origin could be adsorbed onto particle surface and, hence, exert their own 
toxicity. The precise underlying mechanisms leading to particulate matter-induced 
adverse health effects remain poorly understood. Moreover, determining which 
components, i.e. particulate core, adsorbed constituent or both, are involved is often 
difficult. To circumvent this complex issue, several studies have used coarse, fine or 
ultrafine carbon or TiO2 particles as a surrogate for airborne particulate matter 
(Donaldson et al., 2003). Those surrogate particles are homogenous in size and 
relatively free of adsorbed constituents. In line with the aforementioned observations, 
the present study was designed to investigate the influence of different nanoparticles’ 
cores on vasomotor responses in rat intrapulmonary arteries, since the pulmonary 
circulation could be a privileged target of inhaled particles, and any dysfunction in 
pulmonary vascular homeostasis may have negative impact on cardiopulmonary 
function. 
 
A direct effect of CNP on intrapulmonary vascular tone was clearly evidenced in rat 
intrapulmonary arteries. By contrast TiO2NP failed to alter vascular tone whatever the 
concentration used. These results indicate that chemical composition of 
nanoparticles determines their biological effects, especially on intrapulmonary 
vascular tone. Furthermore, when using manufactured nanoparticles as surrogate 
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model of ultrafine particulate matter pollution in order to discriminate the biological 
effects of particles core from constituents adsorbed onto particles, the interpretation 
of such observed results should be cautious.  
 
CNP induced a large, sustained and concentration-dependent relaxation in PGF2α 
precontracted pulmonary artery. This relaxation was endothelium independent since 
it was induced in both endothelium intact and endothelium free arteries, and reached 
the same amplitude. In other vascular beds, i.e., rat aorta or mesenteric arteries, 
relaxation elicited by particulate matter has already been observed (Knaapen et al., 
2001 ; Bagaté et al., 2004). A possible mechanism could be the generation of 
reactive oxygen species upon particles exposure that was evidenced in several 
acellular and cellular models (Li et al., 1996; Dick et al., 2003 ; Foucaud et al., 2007), 
including vascular one (Li et al., 2006). Indeed, CNP enhances the production of 
oxidant like H2O2 which has been already reported or suggested to induce 
vasorelaxation of precontracted vessels rings in vitro (Burke and Wolin, 1987 ; Fraile 
et al., 1994 ; Fresquet et al., 2006). Moreover, some studies have demonstrated that 
particulate matter-induced relaxation was reduced using the non-specific antioxidant 
Trolox (Knaapen et al., 2001). Therefore, a relaxation induced by H2O2 derived from 
CNP exposure, or H2O2 generated upon the interaction between CNP and vasoactive 
agents, could be hypothesized in our in vitro pulmonary artery model. 
 
An alternative, and more plausible, explanation is provided by the present 
observation that the biological activity of almost all of the contracting or relaxing 
agents used was strongly diminished after pre-treatment with CNP. Indeed, it can be 
suggested that these agents are adsorbed onto CNP surface reducing their 
availability to their cellular targets and thus their biologically activity. Consistently, for 
a particles concentration similar to those used in the present study, a strong depletion 
of Bovine Serum Albumin (BSA) or cytokines has already been reported after 
exposure to either fine or ultrafine carbon particles (Brown et al., 2000; Kocbach et 
al., 2008), thus suggesting that proteins might be adsorbed onto the CNP surface. 
Cytokines binding was the strongest in the absence of serum (superior to 85% 
binding), and increasing serum or BSA concentration resulted in a significant 
reduction in cytokines binding. In our model, all experiments were performed in the 
absence of serum or BSA. Consistently, we observed a decrease in phenylephrine 
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concentrations after CNP exposure, which likely contributes to decreased biological 
effect of the agonist. 
 
By contrast, the biological activity of the contracting agent KCl and the relaxing agent 
sodium nitroprusside was not affected by CNP treatment suggesting that neither of 
these two agents binds onto nanoparticles surface. Interestingly it should be noticed 
that, among all agents tested in our study, only these two later are inorganic 
chemicals whereas all the others are organic. In line with this, as above mentioned, 
cytokines (i.e. organic compounds) were found not to interact with mineral particles 
(Kocbach et al., 2008). 
 
Although carbon nanoparticles did not interact with KCl, they induced a slight but 
significant decrease in vascular tone in endothelium free vessels precontracted by 
this agent. The relaxant effect of CNP could not be attributed to a general 
deterioration of arterial tone with time since the time-matched control was not 
affected. In arteries, KCl-induced contraction occurred mainly through a rise in 
cytoplasmic calcium concentration after membrane depolarization and subsequent 
opening of VOCC generating an intracellular calcium influx. Additionally after a 
calcium release from intracellular stores, a calcium entry is triggered through the 
activation of SOCC in order to refill intracellular calcium stores (Guibert et al., 2008). 
Activation of VOCC by KCl could also subsequently induce a calcium-induced 
calcium release, which depletes intracellular calcium stores, and stimulates SOCC 
opening. These voltage-gated calcium channels are important pathways for calcium 
influx that trigger excitation-contraction coupling in vessels. They are involved in 
pressure-induced constriction in small arteries and contribute to the dynamic 
regulation of blood pressure in several vascular beds (Sonkusare et al., 2006). Our 
results clearly demonstrate that, unlike the SOCC component, CNP affect the VOCC 
component of KCl-induced contraction. Thus, VOCC alteration in small arteries may 
disrupt the control of vascular tone and alter blood flow repartition in target organs. 
Nevertheless, we observed that acute exposure to CNP did not modify intracellular 
calcium store, assessed by using the [Ca2+]i- sensitive fluorophore indo-1, in isolated 
rat pulmonary vascular smooth muscle cells (data not shown). Therefore it cannot be 
excluded that CNP also modified contractile apparatus sensitization to calcium that 
produced a decrease in vessel tone induced after KCl addition (Ratz et al., 2005). 
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In conclusion, we report that carbon manufactured nanoparticles could alter 
pulmonary vascular tone, whereas another class of nanomaterials, i. e., titanium 
dioxide nanoparticles, did not. The present results demonstrate that carbon 
manufactured nanoparticles affect KCl-induced contraction in rat intralobar 
pulmonary arteries. Additionally, we suggest a binding of organic but not inorganic 
pharmacological agent to manufactured carbon nanoparticles. Such binding that can 
occur with several agents may potentially lead to misinterpretation of results and 
conclusions. Therefore, from a practical point of view, when studying the effects of 
nanoparticles, such interactions should be systematically evaluated prior 
experiments. In addition, the conclusions made from the interpretation of results 
obtained with manufactured nanoparticles used as surrogate of particulate matter 
pollution should also be performed cautiously.  
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Figure legends 
 
Figure 1: Effect of addition of increasing concentrations of nanoparticles on the 
contractile tone induced by 10 µM PGF2 in rat intrapulmonary arteries with (open 
symbol) or without (closed symbol) functional endothelium. Open circles correspond 
to increasing concentrations of titanium dioxide nanoparticles, whereas open and 
closed squares correspond to increasing concentrations of carbon nanoparticles. 
Results are expressed as mean + s.e.m of 3 - 6 experiments. Not significant between 
endothelium intact and endothelium free arteries for CNP. 
 
Figure 2. (a, b): Representative traces of the contractile effect of 10 µM 
PGF2aand CNP-pretreated PGF2(b) in rat intrapulmonary arteries. (c, d): 
Representative traces of the relaxant effect of 10 µM acetylcholine (c) and CNP-
pretreated acetylcholine (d) in rat intrapulmonary arteries. The addition of native 
vasoactive agent is represented by solid arrows, while that of CNP-pretreated agents 
is represented by dashed arrows. 
 
Figure 3. Effect of addition of increasing concentrations of CNP on the contractile 
tone induced by 30 mM KCl in rat intrapulmonary arteries (closed square). Tone of 
time matched control arteries is included for comparison (open square). Results are 
expressed as mean + s.e.m of 6 experiments. **: P < 0.01.  
 
Figure 4. Schematic representation of the experimental protocols, which were used 
to study the SOCC (a) and the VOCC (b) -dependent contraction in rat 
intrapulmonary arteries. (a, b): Representative traces depicting the effect of addition 
of CNP (100 µg/ml) on either SOCC (a) or VOCC (b) -dependent contraction, the 
addition of CNP is indicated by a black arrow. (c, d): Wall tension before (open 
column) and after (closed column) the addition of CNP (100 µg/ml). Results in (c) 
and (d) are expressed as mean + s.e.m of 4 experiments. **: P < 0.01. 
 
Figure 5: Contractile responses to 80 mM KCl (a) or PGF2α (b), and relaxant 
responses to acetylcholine (c) in rat intrapulmonary arteries incubated for 24 h in the 
absence (open square and open column) or in the presence of 200 µg/ml CNP 
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(closed square and closed column). Results are expressed as mean + s.e.m of 8 - 10 
experiments. Not significant between the two conditions. 
 
Figure 6: Contractile responses to 80 mM KCl (a) or PGF2 (b) and relaxant 
responses to acetylcholine (c) in rat intrapulmonary arteries incubated for 24 h in the 
absence (open circle and open column) or in the presence of 200 µg/ml TiO2NP 
(closed circle and closed column). Results are expressed as mean + s.e.m of 5 - 8 
experiments. Not significant between the two conditions. 
 
Figure 7: Contractile responses to 80 mM KCl (a) or PGF2 (b), and relaxant 
responses to acetylcholine (c) in intrapulmonary arteries removed from rats 
intratracheally instilled with 0.9% saline (open square and open column) or 100 µg 
CNP in 0.5 ml saline (closed square and closed column). Results are expressed as 
mean + s.e.m of 7 experiments. Not significant between the two conditions. 
 
Figure 8: Contractile responses to 80 mM KCl (a) or PGF2 (b), and relaxant 
responses to acetylcholine (c) in intrapulmonary arteries removed from rats 
intratracheally instilled with 0.9% saline (open circle and open column) or 100 µg 
TiO2NP in 0.5 ml saline (closed circle and closed column). Results are expressed as 
mean + s.e.m of 3 - 6 experiments. Not significant between the two conditions. 
 
Table 1. Vasomotor responses induced by various contractile or relaxing agents in 
rat intrapulmonary arteries. Vasoactive agents were pre-treated or not with 200 µg/ml 
CNP. The effect of contractile agents is expressed as a pe rcentage of a reference 
contraction induced by 80 mM KCl for each vessel. The effect of relaxing agents is 
expressed in percentage of decrease of the initial tone induced by 10 µM PGF2α. 
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